CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: anthracen-2-amine
Accession: CHEBI:34260
browse the term
Definition: An anthracenamine that has formula C14H11N.
Synonyms: related_synonym: 2-Aminoanthracene; 2-Anthramine; 2-anthracenamine; 2-anthracylamine; 2-anthrylamine; Formula=C14H11N; InChI=1S/C14H11N/c15-14-6-5-12-7-10-3-1-2-4-11(10)8-13(12)9-14/h1-9H,15H2; InChIKey=YCSBALJAGZKWFF-UHFFFAOYSA-N; SMILES=Nc1ccc2cc3ccccc3cc2c1; beta-aminoanthracene
xref: Beilstein:2209414; CAS:613-13-8; Gmelin:1912207; KEGG:C14417
xref_mesh: MESH:C006593
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
ADAM8
ADAM metallopeptidase domain 8
increases expression
ISO
2-anthramine results in increased expression of ADAM8 mRNA
CTD
PMID:23038007
NCBI chr10:133,262,423...133,276,868
Ensembl chr10:133,262,420...133,276,868
G
AEN
apoptosis enhancing nuclease
increases expression
ISO
2-anthramine results in increased expression of AEN mRNA
CTD
PMID:23038007
NCBI chr15:88,604,683...88,632,281
Ensembl chr15:88,621,337...88,632,281
G
ALB
albumin
decreases expression
ISO
2-anthramine results in decreased expression of ALB protein
CTD
PMID:31714650
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
ALDH1A1
aldehyde dehydrogenase 1 family member A1
increases expression
ISO
2-anthramine results in increased expression of ALDH1A1 mRNA
CTD
PMID:23038007
NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442
G
ANXA1
annexin A1
increases expression
ISO
2-anthramine results in increased expression of ANXA1 mRNA
CTD
PMID:23038007
NCBI chr 9:73,151,865...73,170,393
Ensembl chr 9:73,151,865...73,170,629
G
AR
androgen receptor
multiple interactions
EXP
2-anthramine inhibits the reaction [Metribolone results in increased activity of AR protein]
CTD
PMID:18324785
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
G
ATP6V1D
ATPase H+ transporting V1 subunit D
increases expression
ISO
2-anthramine results in increased expression of ATP6V1D mRNA
CTD
PMID:23038007
NCBI chr14:67,337,872...67,359,804
Ensembl chr14:67,294,371...67,360,265
G
CA2
carbonic anhydrase 2
increases expression
ISO
2-anthramine results in increased expression of CAR2 mRNA
CTD
PMID:23038007
NCBI chr 8:85,464,007...85,481,493
Ensembl chr 8:85,463,968...85,481,493
G
CCNG1
cyclin G1
increases expression
ISO
2-anthramine results in increased expression of CCNG1 mRNA
CTD
PMID:23038007
NCBI chr 5:163,437,571...163,457,640
Ensembl chr 5:163,437,569...163,448,199
G
CD46
CD46 molecule
increases expression
ISO
2-anthramine results in increased expression of CD46 mRNA
CTD
PMID:23038007
NCBI chr 1:207,752,038...207,795,516
Ensembl chr 1:207,752,037...207,795,513
G
CD93
CD93 molecule
increases expression
ISO
2-anthramine results in increased expression of CD93 mRNA
CTD
PMID:23038007
NCBI chr20:23,079,360...23,086,324
Ensembl chr20:23,065,139...23,086,324
G
CDH13
cadherin 13
increases expression
ISO
2-anthramine results in increased expression of CDH13 mRNA
CTD
PMID:23038007
NCBI chr16:82,626,969...83,800,640
Ensembl chr16:82,626,965...83,800,640
G
CDKN1A
cyclin dependent kinase inhibitor 1A
increases expression
ISO
2-anthramine results in increased expression of CDKN1A mRNA
CTD
PMID:23038007
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397
G
CDKN1C
cyclin dependent kinase inhibitor 1C
increases expression
ISO
2-anthramine results in increased expression of CDKN1C mRNA
CTD
PMID:23038007
NCBI chr11:2,883,218...2,885,775
Ensembl chr11:2,883,213...2,885,775
G
CXCL8
C-X-C motif chemokine ligand 8
increases expression
EXP
2-anthramine results in increased expression of CXCL8 mRNA
CTD
PMID:29594315
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CYB5A
cytochrome b5 type A
multiple interactions
EXP
CYB5A protein promotes the reaction [CYP1A2 protein results in increased activity of 2-anthramine]
CTD
PMID:15728263
NCBI chr18:74,250,846...74,291,963
Ensembl chr18:74,250,846...74,291,973
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
multiple interactions increases activity affects metabolic processing
EXP
CYB5A protein promotes the reaction [CYP1A2 protein results in increased activity of 2-anthramine] CYP1A2 protein affects the metabolism of 2-anthramine
CTD
PMID:2655891 PMID:15728263
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
G
DCN
decorin
increases expression
ISO
2-anthramine results in increased expression of DCN mRNA
CTD
PMID:23038007
NCBI chr12:91,140,484...91,182,817
Ensembl chr12:91,140,484...91,183,217
G
DDIT4
DNA damage inducible transcript 4
increases expression
ISO
2-anthramine results in increased expression of DDIT4 mRNA
CTD
PMID:23038007
NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
G
DMBT1
deleted in malignant brain tumors 1
increases expression
ISO
2-anthramine results in increased expression of DMBT1 mRNA
CTD
PMID:23038007
NCBI chr10:122,560,754...122,643,736
Ensembl chr10:122,560,665...122,643,736
G
DPH3
diphthamide biosynthesis 3
increases expression
ISO
2-anthramine results in increased expression of DPH3 mRNA
CTD
PMID:23038007
NCBI chr 3:16,257,061...16,264,943
Ensembl chr 3:16,257,061...16,264,969
G
FABP1
fatty acid binding protein 1
increases expression
ISO
2-anthramine results in increased expression of FABP1 mRNA
CTD
PMID:31714650
NCBI chr 2:88,122,982...88,128,062
Ensembl chr 2:88,122,982...88,128,062
G
FABP4
fatty acid binding protein 4
increases expression
ISO
2-anthramine results in increased expression of FABP4 mRNA
CTD
PMID:23038007
NCBI chr 8:81,478,419...81,483,233
Ensembl chr 8:81,478,419...81,483,236
G
FAS
Fas cell surface death receptor
increases expression
ISO
2-anthramine results in increased expression of FAS mRNA
CTD
PMID:23038007
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
G6PC1
glucose-6-phosphatase catalytic subunit 1
increases expression
ISO
2-anthramine results in increased expression of G6PC1 mRNA
CTD
PMID:23038007
NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
G
GCK
glucokinase
increases expression
ISO
2-anthramine results in increased expression of GCK mRNA
CTD
PMID:23038007
NCBI chr 7:44,143,213...44,189,439
Ensembl chr 7:44,143,213...44,198,170
G
GRIA3
glutamate ionotropic receptor AMPA type subunit 3
increases expression
ISO
2-anthramine results in increased expression of GRIA3 mRNA
CTD
PMID:23038007
NCBI chr X:123,184,278...123,490,915
Ensembl chr X:123,184,153...123,490,915
G
GSTA5
glutathione S-transferase alpha 5
increases expression
ISO
2-anthramine results in increased expression of GSTA5 mRNA
CTD
PMID:23038007
NCBI chr 6:52,831,692...52,846,245
Ensembl chr 6:52,831,655...52,840,843
G
HAVCR1
hepatitis A virus cellular receptor 1
increases expression
ISO
2-anthramine results in increased expression of HAVCR1 mRNA
CTD
PMID:31714650
NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396
G
HIF1A
hypoxia inducible factor 1 subunit alpha
increases activity
EXP
2-anthramine results in increased activity of HIF1A protein
CTD
PMID:19502547
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
G
IFNG
interferon gamma
multiple interactions
EXP
[2-anthramine co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG mRNA
CTD
PMID:29594315
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IGFBP2
insulin like growth factor binding protein 2
increases expression
ISO
2-anthramine results in increased expression of IGFBP2 mRNA
CTD
PMID:23038007
NCBI chr 2:216,632,828...216,664,436
Ensembl chr 2:216,632,828...216,664,436
G
IL1B
interleukin 1 beta
decreases expression increases expression
EXP ISO
2-anthramine results in decreased expression of IL1B mRNA 2-anthramine results in increased expression of IL1B mRNA
CTD
PMID:29594315 PMID:31714650
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL2
interleukin 2
multiple interactions
EXP
[2-anthramine co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA
CTD
PMID:29594315
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
G
IL7
interleukin 7
increases expression
ISO
2-anthramine results in increased expression of IL7 mRNA
CTD
PMID:31714650
NCBI chr 8:78,675,044...78,805,463
Ensembl chr 8:78,675,743...78,805,523
G
JAM3
junctional adhesion molecule 3
increases expression
ISO
2-anthramine results in increased expression of JAM3 mRNA
CTD
PMID:23038007
NCBI chr11:134,069,072...134,152,001
Ensembl chr11:134,069,071...134,152,001
G
LAMA5
laminin subunit alpha 5
increases expression
ISO
2-anthramine results in increased expression of LAMA5 mRNA
CTD
PMID:23038007
NCBI chr20:62,309,065...62,367,312
Ensembl chr20:62,307,955...62,367,312
G
MGMT
O-6-methylguanine-DNA methyltransferase
increases expression
ISO
2-anthramine results in increased expression of MGMT mRNA
CTD
PMID:23038007
NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983
G
MMD2
monocyte to macrophage differentiation associated 2
decreases expression
ISO
2-anthramine results in decreased expression of MMD2 mRNA
CTD
PMID:23038007
NCBI chr 7:4,892,245...4,959,187
Ensembl chr 7:4,905,989...4,959,212
G
NHEJ1
non-homologous end joining factor 1
increases expression
ISO
2-anthramine results in increased expression of NHEJ1 mRNA
CTD
PMID:23038007
NCBI chr 2:219,069,357...219,160,815
Ensembl chr 2:219,069,355...219,160,869
G
NRCAM
neuronal cell adhesion molecule
increases expression
ISO
2-anthramine results in increased expression of NRCAM mRNA
CTD
PMID:23038007
NCBI chr 7:108,147,649...108,456,720
Ensembl chr 7:108,147,623...108,456,717
G
PLN
phospholamban
increases expression
ISO
2-anthramine results in increased expression of PLN mRNA
CTD
PMID:23038007
NCBI chr 6:118,548,296...118,561,716
Ensembl chr 6:118,548,296...118,561,716
G
RBP7
retinol binding protein 7
increases expression
ISO
2-anthramine results in increased expression of RBP7 mRNA
CTD
PMID:23038007
NCBI chr 1:9,997,228...10,016,021
Ensembl chr 1:9,997,206...10,016,021
G
SGCB
sarcoglycan beta
increases expression
ISO
2-anthramine results in increased expression of SGCB mRNA
CTD
PMID:23038007
NCBI chr 4:52,020,706...52,038,299
Ensembl chr 4:52,020,706...52,038,299
G
SLC25A37
solute carrier family 25 member 37
increases expression
ISO
2-anthramine results in increased expression of SLC25A37 mRNA
CTD
PMID:23038007
NCBI chr 8:23,528,956...23,575,463
Ensembl chr 8:23,528,956...23,575,463
G
SOX4
SRY-box transcription factor 4
increases expression
ISO
2-anthramine results in increased expression of SOX4 mRNA
CTD
PMID:23038007
NCBI chr 6:21,593,751...21,598,619
Ensembl chr 6:21,593,751...21,598,619
G
SPP1
secreted phosphoprotein 1
increases expression
ISO
2-anthramine results in increased expression of SPP1 mRNA
CTD
PMID:31714650
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
THYN1
thymocyte nuclear protein 1
increases expression
ISO
2-anthramine results in increased expression of THYN1 mRNA
CTD
PMID:23038007
NCBI chr11:134,248,282...134,253,352
Ensembl chr11:134,248,279...134,253,370
G
TNFRSF9
TNF receptor superfamily member 9
increases expression
ISO
2-anthramine results in increased expression of TNFRSF9 mRNA
CTD
PMID:23038007
NCBI chr 1:7,915,871...7,940,839
Ensembl chr 1:7,915,871...7,943,165
G
VXN
vexin
increases expression
ISO
2-anthramine results in increased expression of VXN mRNA
CTD
PMID:23038007
NCBI chr 8:66,493,566...66,518,524
Ensembl chr 8:66,492,326...66,518,524
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all